Autophagy-mediated insulin receptor down-regulation contributes to endoplasmic reticulum stress-induced insulin resistance

Mol Pharmacol. 2009 Sep;76(3):596-603. doi: 10.1124/mol.109.057067. Epub 2009 Jun 18.

Abstract

Endoplasmic reticulum (ER) stress is associated with obesity-induced insulin resistance, yet the underlying mechanisms remain to be fully elucidated. Here we show that ER stress-induced insulin receptor (IR) down-regulation may play a critical role in obesity-induced insulin resistance. The expression levels of IR are negatively associated with the ER stress marker C/EBP homologous protein (CHOP) in insulin target tissues of db/db mice and mice fed a high-fat diet. Significant IR down-regulation was also observed in fat tissue of obese human subjects and in 3T3-L1 adipocytes treated with ER stress inducers. ER stress had little effect on IR tyrosine phosphorylation per se but greatly reduced IR downstream signaling. The ER stress-induced reduction in IR cellular levels was greatly alleviated by the autophagy inhibitor 3-methyladenine but not by the proteasome inhibitor N-benzoyloxycarbonyl (Z)-Leu-Leu-leucinal (MG132). Inhibition of autophagy prevented IR degradation but did not rescue IR downstream signaling, consistent with an adaptive role of autophagy in response to ER stress-induced insulin resistance. Finally, chemical chaperone treatment protects cells from ER stress-induced IR degradation in vitro and obesity-induced down-regulation of IR and insulin action in vivo. Our results uncover a new mechanism underlying obesity-induced insulin resistance and shed light on potential targets for the prevention and treatment of obesity-induced insulin resistance and type 2 diabetes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3T3-L1 Cells
  • Adipocytes / metabolism
  • Animals
  • Autophagy*
  • Disease Models, Animal
  • Down-Regulation
  • Endoplasmic Reticulum / drug effects
  • Endoplasmic Reticulum / metabolism*
  • Humans
  • Insulin Resistance*
  • Leupeptins / pharmacology
  • Mice
  • Mice, Inbred Strains
  • Obesity / complications
  • Obesity / metabolism*
  • Phosphorylation
  • Receptor, Insulin / antagonists & inhibitors*
  • Taurochenodeoxycholic Acid / pharmacology
  • Tyrosine / metabolism

Substances

  • Leupeptins
  • Tyrosine
  • Taurochenodeoxycholic Acid
  • ursodoxicoltaurine
  • Receptor, Insulin
  • benzyloxycarbonylleucyl-leucyl-leucine aldehyde